Figures
Abstract
The use of copper (Cu2+) and cobalt (Co2+) has been described to stimulate blood vessel formation, a key process for the success of tissue regeneration. However, understanding how different concentrations of these ions affect cellular response is important to design scaffolds for their delivery to better fine tune the angiogenic response. On the one hand, gene expression analysis and the assessment of tubular formation structures with human umbilical vein endothelial cells (HUVEC) revealed that high concentrations (10μM) of Cu2+ in early times and lower concentrations (0.1 and 1μM) at later times (day 7) enhanced angiogenic response. On the other hand, higher concentrations (25μM) of Co2+ during all time course increased the angiogenic gene expression and 0.5, 5 and 25μM enhanced the ability to form tubular structures. To further explore synergistic effects combining both ions, the non-toxic concentrations were used simultaneously, although results showed an increased cell toxicity and no improvement of angiogenic response. These results provide useful information for the design of Cu2+ or Co2+ delivery scaffolds in order to release the appropriate concentration during time course for blood vessel stimulation.
Citation: Bosch-Rué E, Díez-Tercero L, Rodríguez-González R, Bosch-Canals BM, Perez RA (2021) Assessing the potential role of copper and cobalt in stimulating angiogenesis for tissue regeneration. PLoS ONE 16(10): e0259125. https://doi.org/10.1371/journal.pone.0259125
Editor: Selvaraj Vimalraj, Anna University, Chennai, INDIA, INDIA
Received: August 6, 2021; Accepted: October 12, 2021; Published: October 27, 2021
Copyright: © 2021 Bosch-Rué et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting information files.
Funding: RAP was funded by the Government of Catalonia (2017 SGR 708), the Spanish Ministry (Ramón y Cajal fellowship (RYC2018-025977-I) and project RTI2018-096088-J-100 (MINECO/FEDER), and EBR, LDT, RRG predoctoral fellowship from Universitat Internacional de Catalunya (UIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
1 Introduction
Tissue regeneration involves different sequential phases in which blood vessel formation is one of the essential phases to ensure a successful tissue formation. For instance, bone regeneration is a multi-step process involving different events such as inflammation of damaged zone, blood vessel formation (angiogenesis), recruitment of osteoprogenitor cells to the zone of healing and their subsequent osteogenic differentiation for bone formation [1]. Bone has a native capacity to regenerate itself in situations in which the size of the defect is small, such as cracks and small fractures. However, when the size of the defect exceeds the critical size, bone has a limited capacity to regenerate itself [2]. Among the different events that take place in bone regeneration, blood vessel formation has been recognized as one of the key processes for the success of bone fracture healing, showing limited regeneration when the vascular network was poorly developed [3]. For this reason, bone defects exceeding ≥ 2.5 cm are unable to regenerate without aid [2], mainly due to lack of vascularization, which leads to necrosis and cell death. Vascularization is generally triggered by the appearance of growth factors that are naturally found in the tissues during regenerative processes and have been proved to be successful in angiogenesis stimulation, as long as a graft is present in the site of defect. In order to mimic the natural angiogenesis process that will eventually promote bone tissue regeneration, the use of synthetic grafts combined with growth factors, such as vascular endothelial growth factor (VEGF), have been used to stimulate blood vessel formation [4]. However, they have delicate handling properties and short half-life. An alternative approach to mimic native cellular functions is the use of ions, which have shown similar functionality as growth factors and that are as well intrinsically found in the human body at low concentrations or as trace elements [5, 6]. An advantage of ions compared to growth factors is their higher stability, allowing longer periods of storage and an easy manipulation [7]. Therefore, in the last years, ions have been considered as a promising alternative.
Among the biological active metal ions, copper (Cu2+) and cobalt (Co2+) have been proposed as good candidates for angiogenesis stimulation, as both ions are described to mimic hypoxic conditions by up-regulating hypoxia inducible factor-1α (HIF-1α). This, in turn, up-regulates angiogenic-related genes, such as vascular endothelial growth factor (VEGF), and therefore, triggers blood vessel formation [8, 9]. Despite their great potential, the doses released from synthetic grafts and hence administered into the site of defect should be in the therapeutic window while avoiding the induction of cytotoxicity. There are several strategies to incorporate ions within these synthetic grafts, allowing a fine tuning of their release upon implantation [10]. Despite the significant number of scaffolds that have incorporated these ions into their structure, the optimum concentrations required at each time point of the angiogenic response are still unknown. Generally, ion release from scaffolds is measured as a cumulative release after several days, obtaining the angiogenic response at the end point of the experiment [11, 12] or in a single time point during the course of the experiment [13–16], which is generally never in the initial hours [17–19]. Hence, it is difficult to understand and design novel scaffolds with optimum concentrations as well as with the adequate release patterns that will match the exact time points at which the different ions need to be present. For this purpose, tissue engineering and scaffold design have the need of systematic experimental plan to unravel these concentrations.
While the use of individual metal ions has proved to be beneficial for the stimulation of different cell functions, combinatorial approaches have demonstrated to induce synergistic effects. For instance, the combination of silicon (Si4+) and strontium (Sr2+) increased the expression of angiogenic genes, such as VEGF and KDR, in HUVEC cells in vitro, and significantly increased the percentage of blood vessel area formation in vivo [20]. In another study, authors demonstrated a significantly stronger stimulatory effect up-regulating angiogenic growth factors when Cu2+ and Si2+ were combined together, requiring lower doses of each one compared with their individual effect [21]. Therefore, the combination of ions might serve as another strategy to stimulate blood vessel formation.
In this study, we aimed to screen a range of concentrations of two hypoxia mimicking ions (Cu2+ and Co2+) in order to evaluate their non-toxic concentrations and, at the same time, to evaluate how different concentrations affects the angiogenic response during early (hours) and later (days) time points. Furthermore, the possible synergistic combinatorial effect of these non-toxic ion concentrations was assessed, in order to open the possibility of combining ions to stimulate angiogenesis as this has not been studied before. Overall, the results may provide insights of how to design tissue engineering scaffolds that release ions for the early control of angiogenesis.
2 Materials & methods
2.1. Cell culture
Human Umbilical Vein Endothelial Cells (HUVEC; Lonza) were used to assess the angiogenic response. For cell expansion, HUVEC were seeded at a density of 2500 cells/cm2 and maintained with endothelial growth medium-2 bulletkit (EGM-2) (Lonza; Ref. H3CC-3162), containing VEGF, rhFGF-B, rhEGF, r-IGF-I, hydrocortisone, ascorbic acid, gentamicin sulfate, amphotericin-B and 2% FBS. When cells reached 70–85% confluence, they were passaged using 0.25% Trypsin-EDTA (Gibco). Cells were maintained in standard culture conditions (37°C and 5% CO2). Passages equal or below P5 were used for subsequent assays. Preliminary experiments tested two types of cell culture media supplemented with ions: i) basal medium (Lonza; Ref. CC-3156), supplemented with 2% FBS and amphotericin-B; ii) and EGM-2 medium, previously described.
2.2. Cell cytotoxicity assay
CuCl2 and CoCl2 (both from Sigma-Aldrich) were used as a source for cell culture media supplementation for Cu2+ and Co2+, respectively. For viability assay, concentrations of Cu2+ tested were 0, 0.1, 1, 10, 100 and 200 μM and for Co2+ concentrations assessed were 0, 0.5, 5, 25, 50 and 100 μM. HUVEC were seeded at a density of 5000 cells/cm2. After 24h of seeding, the culture with ion supplemented medium started for a total of 7 days, with change of media every two days. Viability of cells was assessed using a commercially colorimetric available kit, specifically the Cell Counting Kit-8 (CCK-8) (Sigma-Aldrich). This kit contains a water-soluble tetrazolium salt WST-8 which is reduced by dehydrogenases of cells, resulting in a yellow-colored product (formazan). The amount of formazan generated is considered directly proportional to the number of viable cells, and has an absorbance spectrum peak at 450–460 nm. CCK-8 was performed according to manufacturer’s instructions. Briefly, at time points of 2 and 7 days after medium supplementation with ions, CCK-8 solution was added in each well and incubated with cells for 3 hours. After this period, supernatant was placed in a 96 well plate (Greiner bio-one) and the absorbance was read at 450 nm using a multi-detection microplate reader (Synergy HT, BioTek). Results were normalized with the control medium, which did not contain supplemented ion. Percentages over 80% were considered non-toxic. The viability of HUVEC cells was also assessed with the combination of Cu2+ and Co2+ with the highest and half of the highest non-toxic concentrations that induced an angiogenic response.
2.3. Cell morphology with phalloidin
Cell morphology and organization was performed by immunofluorescence of actin filament staining with phalloidin (Acti-stain 488 fluorescent phalloidin, Cytoskeleton, Inc). For this purpose, 24 well plate coverslips were autoclaved and placed in each well. Then, 20 μL of 1% sterilized gelatin (Sigma-Aldrich) was added on the surface of each coverslip and incubated at room temperature for 30 min. Afterwards, the excess of gelatin was aspirated and 24 well plates were placed in the incubator at 37°C for 30 minutes. After this incubation period, cell culture media was added and HUVEC were seeded in each well with a density of 5000 cells/cm2. After 24h of seeding, the cell culture media was replaced with the one containing ion supplementation, with the concentrations that proved to be non-toxic. Control samples were cultured without ions supplementation. At the time points of 2 and 7 days after medium supplementation, cells were rinsed with PBS 1X and subsequently fixed with 4% PFA during 20 min at room temperature. Next, cells were rinsed three times with PBS 1X and permeabilized with 0.5% Triton-100x/PBS for 10 min. After three washes with PBS 1X, samples were incubated with 100 nM Acti-stain phalloidin (Cytoskeleton, Inc) for 30 min protected from light. Then, after PBS 1X rinsing, cells were incubated with DAPI (NucBlue Fixed Cell stain DAPI, LifeTechnologies) for 5 min. Finally, cells were rinsed one last time with PBS 1X and then, cover slips were detached from 24 well plate and mounted on a microscope slide with Fluoromount-G (BioNova). Samples were kept in the dark at 4°C and they were visualized by confocal laser microscopy (Leica SP8, LAS X software version 3.5.5.19976). Excitation/emission wavelengths were 480/520 nm for phalloidin and 405/460 for DAPI. Images were processed with the same confocal software (LAS X Life Science software, Leica).
2.4. Gene expression RT-qPCR
Gene expression was analyzed by quantitative real time polymerase chain reaction (qPCR) at early time points (1, 2, 4, 10 and 24h) and later time points (day 7 and 7) to assess the early and later angiogenic response, respectively. With the combination of ions, the gene expression was analyzed at day 2 and 7. Cell pellets were collected at time points above mentioned using 0.25% Trypsin-EDTA (Gibco) and spin centrifugation of 1500 rpm for 5 min. Then, total RNA was isolated from cells using NucleoSpin RNA Kit (Macherey-Nagel) including DNAse treatment step following manufacturer’s instructions. Quantification of isolated RNA was performed using a microvolume plate (Take 3) to measure absorbance ratio of wavelengths 260/280 nm in a microplate reader (Synergy HT Multi-detection Microplate Reader, BioTek). A ratio of ~2 was considered pure RNA. Reverse-transcription (RT) of RNA to cDNA was performed using Transcriptor First Strand cDNA Synthesis Kit (Roche) following manufacturer’s instructions using T100 Thermal Cycler (Bio-Rad). For the amplification and quantification of cDNA targets, QuantiNova SYBR Green PCR kit (Qiagen) was used following manufacturer’s instructions. Briefly, 20 ng of cDNA per reaction were amplified under the following conditions: an initial heat activation step of 2 min at 95°C followed by 40 cycles of denaturation for 5s at 95°C and annealing/extension for 10s at 60°C, using a CFX96 Real-Time PCR Detection System (Bio-Rad). The primers sequences used for vascular endothelial growth factor (VEGF), hypoxia-inducible factor 1-alpha (HIF-1α), platelet endothelial cell adhesion molecule-1 (PECAM-1) and the endogen gen beta-actin (β-Actin) are listed in Table 1. To normalize data, β-Actin was used as internal reference for each reaction. Relative expression was calculated using the 2-ΔΔCt method and all data of conditions tested were expressed as fold-changes compared to each time point control to better elucidate the angiogenic effects of the ions through time course.
2.5. Matrigel assay for tubular formation
In vitro tubular formation analysis was performed using Matrigel® Growth Factor Reduced (GFR) (Corning® Matrigel®, Ref. 734–0268) with HUVEC cells in 96 well plates. First, 75 μL of Matrigel at 4°C were transferred to each well and incubated for 10 min at room temperature. After this period, plates were incubated in a humidified incubator at 37°C for 30 min. Then, 75 μL of cell culture media was added to each well. For the conditions of ion supplementation, the supplemented media contained doubled the final desired ion concentration (of non-toxic concentrations). Plates were incubated 30 min at 37°C. Then, 70 000 cells/cm2 were added in each well with a volume of 75 μL. At the time points of 4 and 8h, cells were rinsed once with PBS 1X and fixed with 4% PFA for 30 min. Afterwards, cells were rinsed three times and stored at 4°C with PBS 1X. There were three triplicates per condition and two fields per well were photographed using an inverted microscope coupled with a camera (Nikon Eclipse TS2-S-SM) and its software (IC Measure software). The phase contrast images were analyzed using the freely Angiogenesis Analyzer plugin of Image J. Number of nodes, number of meshes and total tubule length were analyzed.
2.6. Statistical analysis
Statistical analysis was performed using SPSS software (SPSS v21, IBM). Kruskal-Wallis and Mann Whitney U non-parametric tests were used to compare viability, gene expression and tubule formation (number of nodes, meshes and total tubule length) between experimental groups and control of the same time point (data represented as mean ± standard deviation; n = 4 for viability and n = 3 for gene expression and Matrigel assay for each condition). Spearman non-parametric test was used to study the correlation between HIF-1α and VEGF gene expression. Control samples were cells without any supplementation ion in cell culture media.
3 Results
3.1. Viability, proliferation and morphology
3.1.1. Copper (Cu2+).
In order to elucidate the ion concentrations which are not cytotoxic, HUVEC cells were cultivated under different copper (Cu2+) and cobalt (Co2+) concentrations. Additionally, their viability effect was tested with both basal and growth media, to find out which one was more appropriate to use for further assays. Generally, we could observe an increase of detached cells and cell debris (when HUVEC were cultivated with basal medium (BM) (S1 Fig) compared to growth medium (GM) (S2 Fig). Moreover, a reduction of cells was observed in a dose-dependent manner during culture time when Cu2+ was added in both cell culture mediums, which was more evident with BM.
Results of viability assays were in accordance with the observations of cell culture. With BM, all the concentrations tested resulted to be cytotoxic at the end of culture (S3 Fig). Alternatively, when HUVEC were cultured with GM supplemented with Cu2+, they presented a proper viability with Cu2+ concentrations up to 10 μM (Fig 1A). Due to these viability results, we considered to use GM for the subsequent assays.
(A) HUVEC viability cultured with different concentrations of Cu2+ (0, 0.1, 1, 10, 100 and 200 μM) at day 2 and 7. (B) HUVEC morphology cultured with different non-toxic concentrations of Cu2+ (0, 0.1, 1 and 10 μM) at day 2 and 7 (actin filament staining (green); nucleus (blue). Scale bar = 50 μm. Statistically significant differences were represented with * (p<0.05).
The influence of Cu2+ on cell morphology and arrangement was evaluated with actin filament staining. At day 2, no apparent differences between control and experimental groups were observed (Fig 1B). From 2 to 7 days, cells reached confluence and started to grow and proliferate over the monolayer, and some cells acquired an elongated phenotype.
3.1.2. Cobalt (Co2+).
Regarding HUVEC culture with BM supplemented with Co2+, there were high amounts of cell debris and detached cells compared with GM (S4 and S5 Figs). These observations were more evident when the concentration of Co2+ was increased, which was in accordance with viability results. With BM, all the concentrations resulted to be cytotoxic at the end of the experiment, (S6 Fig). Alternatively, when HUVEC cells were cultured with GM supplemented with Co2+, concentrations up to 50 μM demonstrated to be not toxic for HUVEC at the end of culture (Fig 2A). Considering the lower viability of cells with BM, we decided to use GM for the subsequent assays.
(A) HUVEC viability cultured with different concentrations of Co2+ (0, 0.5, 5, 25, 50 and 100 μM) at day 2 and 7 (n = 4). (B) HUVEC morphology cultured with different non-toxic concentrations of Co2+ (0, 0.5, 5, 25 and 50 μM) at day 2 and 7 (actin filament staining (green); nucleus (blue). Scale bar = 50 μm. Statistically significant differences were represented with * (p<0.05).
With regards to HUVEC morphology, there were less number of cells with higher concentrations compared to control (Fig 2B). From day 2 to 7, HUVEC reached confluence and some cells proliferated over the monolayer with an elongated morphology although this was not observed with 50 μM.
3.2. Ion influence on angiogenesis gene expression
To further assess the potential of Cu2+ and Co2+ in stimulating angiogenic response in HUVEC, we analyzed the expression of three principal genes involved in the angiogenic response: HIF-1α, VEGF and PECAM-1. For this purpose, the gene expression profile was analyzed in a short period of hours (1, 2, 4, 10 and 24h), and subsequently, in longer periods (2 and 7 days), to assess the early and later angiogenic response, respectively.
3.2.1. Copper (Cu2+).
In general, within the initial hours, HUVEC cultured with Cu2+ showed only a significant increase at 10h with 10 μM concentration (Fig 3A). Regarding the VEGF expression profile, it is worth mentioning that all Cu2+ concentrations induced a significantly higher VEGF expression within 1h in a dose-dependent manner compared to control, and the conditions of 0.1 and 10 μM could also increase it at 10h (Fig 3B). Finally, PECAM-1 expression was significantly up-regulated at different time points (1, 10 and 24h) with different conditions, being 10 μM able to increase it in all of them (Fig 3C).
Different Cu2+ concentrations were evaluated at 1, 2, 4, 10 and 24h for the gene expression of (A) HIF-1α, (B) VEGF and (C) PECAM-1. Different Cu2+ concentrations were also evaluated at 2 and 7 days for the expression of (D) HIF-1α, (E) VEGF and (F) PECAM-1. Data represented correspond to fold-changes compared to each time point control. Statistically significant differences were represented with * (p<0.05).
At day 2, HUVEC HIF-1α expression analysis revealed similar expression with no significant differences compared to control (Fig 3D). At day 7, HIF-1α was significantly increased with the lowest concentration of 0.1 and 1 μM. Regarding VEGF expression at day 2, all Cu2+ concentrations significantly up-regulated it compared to control, in a dose-dependent manner (Fig 3E). Remarkably, 10 μM concentration induced 2.5 fold VEGF expression compared to control, and at the same time, it was higher than VEGF expression induced by 0.1 and 1 μM. Interestingly, at day 7 all the concentrations tested induced a higher VEGF expression compared to control. It is worth mentioning that 0.1 μM induced the highest effect with two-fold VEGF expression. Finally, PECAM-1 expression remained the same for all experimental conditions at day 2 and was significantly increased in a dose-dependent manner by 0.1 and 1 μM at day 7 (Fig 3F).
As HIF-1α is described to transcribe VEGF gene, we further assessed if there was a correlation between HIF-1α and VEGF expression (S1 Table). Although a significant correlation at 2 and 4h was found, there was no significant and strong correlation between the gene expression of HIF-1α and VEGF.
3.2.2. Cobalt (Co2+).
When HUVEC were cultured with Co2+ supplementation, results of HIF-1α expression within initial hours in general revealed an up-regulation at 1, 10 and 24h (Fig 4A). Regarding VEGF expression, there was an up-regulation at 1, 2 and 10h (Fig 4B). It is worth mentioning that, at 1h, all Co2+ concentrations tested induced a higher VEGF expression compared to control, presenting 3 fold expression with 5 and 25 μM conditions. Finally, PECAM-1 expression was up-regulated at 1, 2, 10 and 24h, being worth to mention that 5 and 25 μM induced more than 3 fold expression at 1h (Fig 4C).
Different Co2+ concentrations were evaluated at 1, 2, 4, 10 and 24h for the gene expression of (A) HIF-1α, (B) VEGF and (C) PECAM-1. Different Co2+ concentrations were also evaluated at 2 and 7 days for the expression of (D) HIF-1α, (E) VEGF and (F) PECAM-1. Data represented correspond to fold-changes compared to each time point control. Statistically significant differences were represented with * (p<0.05).
In later time points, at day 2, HUVEC HIF-1α expression analysis showed a gradual increase in a dose-dependent manner, being a significant up-regulation with 5, 25 and 50 μM compared to control (Fig 4D). Later on, at day 7, only 25 μM induced a significant increase of HIF-1α expression. A similar trend was observed with VEGF expression. At day 2, there was a significant up regulation of VEGF for all concentrations tested in a dose-dependent manner, reaching 3-fold expression with 50 μM compared to its time point control (Fig 4E). At day 7, only 25 and 50 μM showed an up-regulation of VEGF expression. Finally, PECAM-1 expression at day 2 and 7 was significantly up-regulated by higher concentrations, specifically 25 and 50 μM, reaching almost 2.5 fold expression (Fig 4F).
As previously mentioned, HIF-1α is described to transcribe VEGF expression. For this reason, we further assessed if there was a correlation between HIF-1α and VEGF expression with Co2+ supplementation (S2 Table). Statistical results show significant and strong correlation between the expressions of these two genes.
3.3. Tubule formation ability
The ability of Cu2+ and Co2+ to promote formation of tubular-like structures was further assessed by culturing HUVEC on Matrigel substrate.
3.3.1. Copper (Cu2+).
In general, with Cu2+ supplementation, thicker tubular structures were observed in comparison to control samples with phase contrast images at 4 and 8 hours (Fig 5A). The results of number of nodes at 4h resulted in an increase in a dose-dependent manner with Cu2+ supplementation, although it was only statistically significant with 10 μM (Fig 5B). At 8h, the number of nodes decreased in all conditions compared to 4h. Regarding the number of meshes and total tube length, no significant differences were found between experimental conditions and control for the same time point (Fig 5C and 5D).
(A) Images of tubules formed under different non-toxic concentrations of Cu2+ (0, 0.1, 1 and 10 μM) at 4 and 8h. (B) Analysis of number of nodes, (C) meshes and (D) total tube length of HUVEC under different Cu2+ concentrations at 4 and 8 hours. Scale bar = 50 μm. Statistically significant differences were represented with * (p<0.05).
3.3.2. Cobalt (Co2+).
The assessment of Co2+ influence in tubule-like structures formation showed, in general, broken vascular structures with 50 μM concentration at 4 and 8h (Fig 6A). Moreover, control at 8h also showed broken vascular network. Regarding the analysis of number of nodes, number of meshes and total tube length, a similar pattern was observed. More specifically, at 4h, there was a significant increase in the number of nodes with 0.5, 5 and 25 μM (Fig 6B). A significant increase was also observed at 4h with 5 μM of Co2+ regarding the number of meshes and total tube length (Fig 6C and 6D). At 8h, no significant increase was observed between experimental groups and control regarding the number of nodes, number of meshes and total tube length (Fig 6B–6D). However, a significant decrease was observed in all parameters with 50 μM.
(A) Images of tubules formed under different non-toxic concentrations of Co2+ (0, 0.5, 5, 25 and 50 μM) at 4 and 8 hours. (B) Analysis of number of nodes, (C) meshes and (D) total tube length of HUVEC under different Co2+ concentrations at 4 and 8 hours. Scale bar = 50 μm. Statistically significant differences were represented with * (p<0.05).
3.4. Influence of dual ion culture on viability, proliferation and morphology
Additionally to the individual ion evaluation in angiogenesis response, we wanted to elucidate if the combination of both ions could have synergistic effects. To this purpose, we selected the concentration of 10 μM of Cu2+, which demonstrated an important increase of VEGF at early time points, and the concentration of 25 μM of Co2+, which also showed a significant improvement of VEGF and PECAM-1 at early and later time points. This combination was coded as Cu10/Co25. As we considered the possibility that the combination of these two higher concentrations could be cytotoxic for cells due to their ability to form reactive oxygen species (ROS) when they are at high concentrations, we also assessed the combination of half of these concentrations, being 5 μM for Cu2+ and 12.5 μM for Co2+, coded as Cu5/Co12.5.
Results obtained with viability analysis showed that cells cultured with Cu5/Co12.5 and Cu10/Co25 reached a viability of almost 80% at day 2, but it was reduced down to 62% and 52% at day 7, respectively, being significantly lower compared to control (Fig 7A).
(A) Viability and (B) morphology of HUVEC under different combinations of Cu2+ and Co2+ (actin filament staining (green); nucleus (blue). Scale bar = 50 μm. Abbreviations: Cu5/Co12.5 = 5 μM of Cu2+ and 12.5 μM of Co2+; Cu10/Co25 = 10 μM of Cu2+ and 25 μM of Co2+. Statistically significant differences were represented with * (p<0.05).
The influence of the combination of both ions on HUVEC morphology and organization was also evaluated with actin filament staining. At day 2, there were no apparent differences between experimental conditions (Fig 7B). At day 7, control samples reached confluence and HUVEC cells grew over it. Regarding both combination of ions, there were no differences regarding morphology compared to control.
3.5. Influence of dual ion culture on angiogenesis
To our surprise, the evaluation of angiogenic gene expression did not show any significant up or down-regulation of HIF-1α, VEGF or PECAM-1 for any of the combinations tested compared to control samples (Fig 8). As a final assessment, tubule formation capability of HUVEC under both ion combinations was also assessed with Matrigel as a substrate. Apparently, with phase contrast images there seemed to be no differences between all conditions tested (Fig 9A). Results of the analysis of number of nodes, number of meshes and total tube length resulted in non-statistically significant differences between experimental groups for each time point, confirming the previous observations (Fig 9A–9C).
Different Cu2+ and Co2+ concentrations were evaluated at 2 and 7 days for the expression of (A) HIF-1α, (B) VEGF and (C) PECAM-1. Data represented correspond to fold-changes compared each time point control. Abbreviations: Cu5/Co12.5 = 5 μM of Cu2+ and 12.5 μM of Co2+; Cu10/Co25 = 10 μM of Cu2+ and 25 μM of Co2+.
(A) Images of tubules formed under different concentrations of Cu2+ and Co2+ at 4 and 8 hours. (B) Analysis of number of nodes, (C) meshes and (D) total tube length of HUVEC at 4 and 8 hours. Abbreviations: Cu5/Co12.5 = 5 μM of Cu2+ and 12.5 μM of Co2+; Cu10/Co25 = 10 μM of Cu2+ and 25 μM of Co2+. Scale bar = 50 μm.
4 Discussion
In order to use therapeutic ions for angiogenesis stimulation, a screening for non-toxic concentrations that at the same time induce a therapeutic effect is required. In this study, Cu2+ and Co2+ were selected, both described to be angiogenic, with the aim to elucidate how different concentrations affect the angiogenic response during time course (within hours and days), to determine which are the appropriate concentrations to be delivered when an ion delivering scaffold wants to be designed. As it is reported that the combination of some ions have a synergistic effects [20, 21], the combination of Cu2+ and Co2+ was also assessed in this study, as it has not been addressed before to the best of our knowledge.
The different assays were performed with growth media (GM) due to the presence of cell debris and detached cells with difficulties to proliferate with basal media (BM). Results showed non-toxic concentrations up to 10 μM for Cu2+ and 50 μM for Co2+ (Figs 1A and 2A). Decrease of cell viability with high concentrations of ions might be due to cellular toxicity induced by reactive oxygen species (ROS). In the presence of superoxide (·O2-) (produced by the mitochondria during cellular respiration) or reducing agents, such as glutathione (GSH) or ascorbic acid (generally found in cells [22] and in cell culture media that we used for the experiments, respectively), Cu2+ can be reduced to Cu+, which in turn, can catalyze the formation of hydroxyl radicals (OH·) from hydrogen peroxide (H2O2) (produced during normal cell metabolism [23]), through Haber-Weiss reaction [24]:
Similarly, Co2+ has also been described to be involved in ROS formation [25, 26]. More specifically, with the presence of oxygen, Co2+ might generate the radical intermediate Co+-OO· species [27]:
With the presence of superoxide dismutase enzyme (SOD) (an antioxidant enzyme present in cells [28]), it can catalyze the decomposition of Co+-OO· species to H2O2 and Co+:
Finally, it was proposed that Co+ could participate in the formation of OH· radicals through Fenton reaction:
Results of HUVEC viability when both ions were combined support the proposed equations of ROS generation by Cu2+ or Co2+ discussed in the literature. Surprisingly, HUVEC viability was considerably reduced in the presence of both ions (Fig 7A), compared to the viability with individual ions (Figs 1A and 2A). As observed in ROS generation equations, Cu2+ generates O2, whereas Co2+ consumes it. Therefore, there is the possibility that the presence of both ions might feedback the formation of ROS. Furthermore, it is widely reported that the generation of ROS can result in DNA damage, lipid peroxidation, depletion of protein sulfhydryls and other effects that leads to apoptosis of cells [27], and that might explain the decreased viability of cells when the concentrations of ions were increased. To confirm low viability due to ROS formation, further studies including quantification of ROS species will need to be undertaken.
Comparing viability results of HUVEC cultured with Cu2+ with published ones, we found similarities with another study. Similarly, they reported a decreased HUVEC viability when cultured with concentrations equivalent to 7, 21 and 63 μM compared to control [29]. However, our results differ from other studies reporting viability of HUVEC up to 50 μM [30] or 500 μM [31]. These differences might be due to the time of exposure of Cu2+, which was relatively short for the later studies (48h), whereas in our study and the one with similar results [29] the Cu2+exposure was up to 7 and 14 days respectively. Regarding Co2+, similar to our results, Peters et al., described a proliferation decrease in a dose-concentration manner with concentrations of 10, 50, 100, 300 and 700 μM [32]. Conversely, Tao Zan et al reported an enhanced proliferation of EC in a dose-dependent manner with Co2+ concentrations of 50, 100 and 200 μM [33]. These differences might be due to the degree of differentiation of EC. Endothelial progenitor cells (EPC) are described to possess higher antioxidant capacity than mature endothelial cells such as HUVEC [34], therefore, being resistant to oxidant cytotoxicity generated by ROS. Tao Zan et al used EPC for their study, and that might explain the absence of toxicity up to 200 μM.
Non-toxic concentrations of Cu2+ (≤10 μM) demonstrated an enhancement of angiogenic response both in a gene expression level and in the ability to form tubular structures. Regarding the gene expression our results demonstrated that, in a wide overview, higher concentrations (10 μM) of Cu2+ have a significant contribution in angiogenesis at early time points observed with VEGF and PECAM-1 expression (up to day 2), whereas lower concentrations (0.1 and 1μM) have a more therapeutic effect at later stages (day 7) (Fig 3). Statistical analysis revealed no correlation between HIF-1α and VEGF expression (S1 Table), however, a previous study described that Cu2+ can enhance angiogenic response by the stabilization and increase of HIF-1α, which in turn triggers VEGF transcription [8]. Our findings are in agreement with a later published study, in which authors suggested that Cu2+ might be required for the binding of HIF-1α to hypoxia response element (HRE) sequence of target genes such as VEGF, but its deprivation did not affect the expression or stability of HIF-1α (total amount of HIF-1α in cells) but it did decrease VEGF expression [35]. Therefore, authors suggest that Cu2+ does not increase HIF-1α expression, but it is required for HIF-1 transcriptional complex formation. This might explain why we could observe an increase of VEGF although it was not correlated with HIF-1α expression. In addition, we observed a significant increase of PECAM-1 expression with higher doses at early times (10 μM at 24h) and with lower doses at later times (0.1 and 1 μM at day 7). It has been described that PECAM-1 is involved in endothelial cell migration and angiogenesis [36–38], and a reduction of blood vessel formation was reported when being inhibited [39]. Therefore, PECAM-1 expression results further suggests an enhancement of angiogenic response with Cu2+. Gene expression results of VEGF and PECAM-1 seem to be in accordance with results obtained with tubule formation assay (Fig 5). More specifically, an increase of number of nodes and meshes was observed with the high concentration of 10 μM at 4h, whereas at later time point, the increase was observed with 0.1 μM. Therefore, our results suggest that Cu2+ is able to establish a higher degree of vascular network connections with concentrations ranging from 0.1 to 10 μM.
Non-toxic concentrations of Co2+ (≤50 μM) could also demonstrate an enhancement of angiogenic response, although differences were found with the highest therapeutic dose between gene expression results and the ability to form tubular structures. Regarding results of gene expression induced by Co2+, although lower concentrations can enhance the angiogenic response within hours, it seems that higher concentrations of 25 and 50 μM enhance the response either at 2 and 7 days through the increase of HIF-1α, VEGF and PECAM-1 expression (Fig 4). Remarkably, we found a strong and significant correlation between HIF-1α and VEGF expression (S2 Table). These results are similar to a previous study demonstrating that Co2+ induced increased HIF-1α and VEGF expression in a dose-dependent manner, although the concentrations that they used were higher, specifically 50, 100 and 200 μM [33]. Authors mentioned that Co2+ act as prolyl hydroxylation inhibitor, hence inhibiting HIF-1α degradation and stabilizing it, with subsequent VEGF expression. Moreover, the up-regulation of PECAM-1 expression with high concentrations further indicates an enhancement of angiogenic response. Alternatively, the results obtained from tubule formation assay indicated that Co2+ have an effect in vascular structure formation (Fig 6). More specifically, there was an increase of number of nodes, number of meshes and total tube length with 0.5, 5 and 25 μM at early time of 4h. Importantly, the highest concentration of 50 μM induced an impairment of angiogenesis at 8h. This impairment was in accordance with a previous study where the in-vitro capillary formation of human EC was impaired with Co2+ concentrations of 50, 100 and 300 μM [32]. The authors hypothesized that Co2+ exposure could induce interference of integrin signaling, which is normally regulated by divalent metal ions such as Ca2+, Mg2+ and Mn2+. Integrins recognize and respond to a variety of extracellular matrix proteins [40] and their signaling interference can lead to a loss of EC adhesion [41], which might be an explanation for the impairment of vascular network structures formation with the highest concentration of Co2+.
Finally, as we observed an enhanced angiogenic response with individual culture of Cu2+ and Co2+ with HUVEC, we further evaluated the response when combined together. As far as we know, no previous studies are reported analyzing the role of these two ions combined together, neither as cell culture media supplement or as delivered from scaffolds. To our surprise, we could not observe any significant up or down-regulation of HIF-1α, VEGF or PECAM-1 between conditions during all time course of the experiment (Fig 8), or any significant difference of number of nodes, number of meshes and total tube length with the in vitro tubule formation assay compared to control (Fig 9). As we observed differences when both ions were cultured individually, these results point to the likelihood that both ions are mutually inhibiting or interacting with each other when being together. A possible hypothesis is that copper and cobalt might interact with some components of the cell culture media forming new complexes. In this regard, it is described in the literature that copper and cobalt can interact with each other with the presence of histidine, forming a new complex Co-Cu-His [42]. As aminoacids, being histidine one of them, are added in the cell culture media formulations as essential nutrients [43], the possibility of forming the complex Co-Cu-His is possible. This would eventually explain why there is no increase in the angiogenesis response, as copper and cobalt might not be found freely to be able to enhance the HIF-1α binding to HRE (copper) and to inhibit the HIF-1α degradation (cobalt). However, future research is needed to test this hypothesis regarding the lack of synergy when both ions are combined together.
The results obtained in this study regarding the individual effects of ions provide useful information for the design of scaffolds for the delivery of Cu2+ or Co2+ in tissue engineering field. Fig 10 shows schematic representation of the different doses of Cu2+ and Co2+ that proved to enhance the angiogenic response, either increasing VEGF or PECAM-1 and improving the ability to form tubule structures, through time course up to 7 days. The released amount from scaffolds within these ranges of concentrations might have the potential to stimulate blood vessel formation.
(A) Profile of doses of Cu2+ and Co2+ that enhanced the angiogenic response within hours and days and (B) the corresponding cumulative release. Representation made based on VEGF and PECAM-1 gene expression and tubule formation assay results.
5 Conclusions
The results of this study indicate that Cu2+ and Co2+ ions individually enhanced the angiogenic response in HUVEC cells with different concentrations, although results showed that some concentrations have earlier therapeutic effects than others. Higher concentrations of Cu2+ have an early angiogenic effect, whereas lower concentrations are required for the increase of angiogenic response at later time points. Alternatively, in a wide overview, higher doses of Co2+ stimulates an angiogenic response at early and later times. These results have important implications regarding the design of Cu2+ or Co2+ delivery scaffolds when blood vessel formation wants to be stimulated at early or later times. Otherwise, our results indicate that the combination of both ions should be avoided.
Supporting information
S1 Fig. Optical images of HUVEC cultured with Cu2+ supplemented basal media.
https://doi.org/10.1371/journal.pone.0259125.s001
(TIFF)
S2 Fig. Optical images of HUVEC cultured with Cu2+ supplemented growth media.
https://doi.org/10.1371/journal.pone.0259125.s002
(TIFF)
S3 Fig. HUVEC cultured with Cu2+ with basal medium.
Viability of HUVEC cultured with basal medium supplemented with Cu2+. Statistically significant differences were represented with * (p<0.05).
https://doi.org/10.1371/journal.pone.0259125.s003
(TIFF)
S4 Fig. Optical images of HUVEC cultured with Co2+ supplemented basal media.
https://doi.org/10.1371/journal.pone.0259125.s004
(TIFF)
S5 Fig. Optical images of HUVEC cultured with Co2+ supplemented growth media.
https://doi.org/10.1371/journal.pone.0259125.s005
(TIFF)
S6 Fig. HUVEC cultured with Co2+ with basal medium.
Viability of HUVEC cultured with basal medium supplemented with Co2+. Statistically significant differences were represented with * (p<0.05).
https://doi.org/10.1371/journal.pone.0259125.s006
(TIF)
S1 Table. HIF-1α and VEGF expression correlation results with Cu2+ supplementation.
Symbols: ns = non-significant (p>0.05); * = p<0.05; ** = p<0.01.
https://doi.org/10.1371/journal.pone.0259125.s007
(TIF)
S2 Table. HIF-1α and VEGF expression correlation results with Co2+ supplementation.
Symbols: ns = non-significant (p>0.05); * = p<0.05; ** = p<0.01.
https://doi.org/10.1371/journal.pone.0259125.s008
(TIF)
References
- 1. Newman MR, Benoit DSW. Local and targeted drug delivery for bone regeneration. Curr Opin Biotechnol. 2016;40: 125–132. pmid:27064433
- 2. Schemitsch EH. Size Matters: Defining Critical in Bone Defect Size! J Orthop Trauma. 2017;31: S20–S22. pmid:28938386
- 3. Dickson K, Katzman S, Delgado E, Contreras D. Delayed Unions and Nonunions of Open Tibial Fractures. Correlation With Arteriography Results. Clin Orthop Relat Res. 1994;302: 189–193. pmid:8168299
- 4. Hu K, Olsen BR. The roles of vascular endothelial growth factor in bone repair and regeneration. Bone. 2016;91: 30–38. pmid:27353702
- 5. Mouriño V, Cattalini JP, Boccaccini AR. Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments. J R Soc Interface. 2012;9: 401–19. pmid:22158843
- 6. Perez RA, Seo SJ, Won JE, Lee EJ, Jang JH, Knowles JC, et al. Therapeutically relevant aspects in bone repair and regeneration. Mater Today. 2015;18: 573–589.
- 7. Holzapfel BM, Reichert JC, Schantz JT, Gbureck U, Rackwitz L, Nöth U, et al. How smart do biomaterials need to be? A translational science and clinical point of view. Adv Drug Deliv Rev. 2013;65: 581–603. pmid:22820527
- 8. Martin F, Linden T, Katschinski DM, Oehme F, Flamme I, Mukhopadhyay CK, et al. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: Implications for ceruloplasmin regulation. Blood. 2005;105: 4613–4619. pmid:15741220
- 9. Yuan Y, Hilliard G, Ferguson T, Millhorn DE. Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α. J Biol Chem. 2003;278: 15911–15916. pmid:12606543
- 10. Bosch-Rué E, Diez-Tercero L, Giordano-Kelhoffer B, Delgado LM, Bosch BM, Hoyos-Nogués M, et al. Biological Roles and Delivery Strategies for Ions to Promote Osteogenic Induction. Front Cell Dev Biol. 2020;8. pmid:33520992
- 11. Kulanthaivel S, Roy B, Agarwal T, Giri S, Pramanik K, Pal K, et al. Cobalt doped proangiogenic hydroxyapatite for bone tissue engineering application. Mater Sci Eng C. 2016;58: 648–658. pmid:26478356
- 12. Xu X, Lu Y, Li S, Guo S, He M, Luo K, et al. Copper-modified Ti6Al4V alloy fabricated by selective laser melting with pro-angiogenic and anti-inflammatory properties for potential guided bone regeneration applications. Mater Sci Eng C. 2018;90: 198–210. pmid:29853083
- 13. Zhang J, Wu H, He F, Wu T, Zhou L, Ye J. Concentration-dependent osteogenic and angiogenic biological performances of calcium phosphate cement modified with copper ions. Mater Sci Eng C—Mater Biol Appl. 2019;99: 1199–1212. pmid:30889654
- 14. Lin Z, Cao Y, Zou J, Zhu F, Gao Y, Zheng X, et al. Improved osteogenesis and angiogenesis of a novel copper ions doped calcium phosphate cement. Mater Sci Eng C. 2020;114: 111032. pmid:32993975
- 15. Jaidev LR, Kumar S, Chatterjee K. Multi-biofunctional polymer graphene composite for bone tissue regeneration that elutes copper ions to impart angiogenic, osteogenic and bactericidal properties. Colloids Surfaces B Biointerfaces. 2017;159: 293–302. pmid:28802737
- 16. Wu C, Zhou Y, Fan W, Han P, Chang J, Yuen J, et al. Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering. Biomaterials. 2012;33: 2076–2085. pmid:22177618
- 17. Yu W, Sun TW, Ding Z, Qi C, Zhao H, Chen F, et al. Copper-doped mesoporous hydroxyapatite microspheres synthesized by a microwave-hydrothermal method using creatine phosphate as an organic phosphorus source: application in drug delivery and enhanced bone regeneration. J Mater Chem B. 2017;5: 1039–1052. pmid:32263882
- 18. Zhou J, Zhao L. Hypoxia-mimicking Co doped TiO2 microporous coating on titanium with enhanced angiogenic and osteogenic activities. Acta Biomater. 2016;43: 358–368. pmid:27477850
- 19. Perez RA, Kim JH, Buitrago JO, Wall IB, Kim HW. Novel therapeutic core-shell hydrogel scaffolds with sequential delivery of cobalt and bone morphogenetic protein-2 for synergistic bone regeneration. Acta Biomater. 2015;23: 295–308. pmid:26054564
- 20. Lin K, Xia L, Li H, Jiang X, Pan H, Xu Y, et al. Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics. Biomaterials. 2013;34: 10028–10042. pmid:24095251
- 21. Kong N, Lin K, Li H, Chang J. Synergy effects of copper and silicon ions on stimulation of vascularization by copper-doped calcium silicate. J Mater Chem B. 2014;2: 1100–1110. pmid:32261627
- 22. Pizzorno J. Glutatione! Integr Med. 2014;13: 8–12.
- 23.
Alim I, Haskew-Layton RE, Aleyasin H, Guo H, Ratan RR. Spatial, temporal, and quantitative manipulation of intracellular hydrogen peroxide in cultured cells. 1st ed. mitochondrial function. Elsevier Inc.; 2014. https://doi.org/10.1016/B978-0-12-801415-8.00014-X pmid:25416362
- 24. Gaetke LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology. 2003;189: 147–163. pmid:12821289
- 25. Zou W, Yan M, Xu W, Huo H, Sun L, Zheng Z, et al. Cobalt chloride induces PC12 cells apoptosis through reactive oxygen species and accompanied by AP-1 activation. J Neurosci Res. 2001;64: 646–653. pmid:11398189
- 26. Pulido MD, Parrish AR. Metal-induced apoptosis: Mechanisms. Mutat Res—Fundam Mol Mech Mutagen. 2003;533: 227–241. pmid:14643423
- 27. Valko M, Morris H, Cronin M. Metals, Toxicity and Oxidative Stress. Curr Med Chem. 2005;12: 1161–1208. pmid:15892631
- 28. Culotta VC, Yang M, O’Halloran TV. Activation of superoxide dismutases: Putting the metal to the pedal. Biochim Biophys acta-molecular cell Res. 2006;1763: 747–758. pmid:16828895
- 29. Stähli C, Muja N, Nazhat SN. Controlled copper ion release from phosphate-based glasses improves human umbilical vein endothelial cell survival in a reduced nutrient environment. Tissue Eng—Part A. 2013;19: 548–557. pmid:23298240
- 30. Li S, Xie H, Li S, Kang YJ. Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway. Exp Biol Med. 2012;237: 77–82. pmid:22185917
- 31. Hu GF. Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem. 1998;69: 326–335. pmid:9581871
- 32. Peters K, Schmidt H, Unger RE, Kamp G, Pröls F, Berger BJ, et al. Paradoxical effects of hypoxia-mimicking divalent cobalt ions in human endothelial cells in vitro. Mol Cell Biochem. 2005;270: 157–166. pmid:15792365
- 33. Zan T, Du Z, Li H, Li Q, Gu B. Cobalt chloride enhances angiogenic potential of CD133 cells. Front Biosci. 2012;17: 2247–2258.
- 34. He T, Peterson TE, Holmuhamedov EL, Terzic A, Caplice NM, Oberley LW, et al. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol. 2004;24: 2021–2027. pmid:15319267
- 35. Feng W, Ye F, Xue W, Zhou Z, Kang YJ. Copper regulation of hypoxia-inducible factor-1 activity. Mol Pharmacol. 2009;75: 174–182. pmid:18842833
- 36. Lertkiatmongkol P, Liao D, Mei H, Hu Y, Newman PJ. Endothelial functions of PECAM-1 (CD31). Curr Opin Hematol. 2016;23: 253–259. pmid:27055047
- 37. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol. 1997;151: 671–677. pmid:9284815
- 38. Yang S, Graham J, Kahn JW, Schwartz EA, Gerritsen ME. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol. 1999;155: 887–895. pmid:10487846
- 39. Cao G, O’Brien CD, Zhou Z, Sanders SM, Greenbaum JN, Makrigiannakis A, et al. Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol—Cell Physiol. 2002;282. pmid:11940533
- 40. Short SM, Talbott GA, Juliano RL. Integrin-mediated signaling events in human endothelial cells. Mol Biol Cell. 1998;9: 1969–1980. pmid:9693360
- 41. Peters K, Unger RE, Barth S, Gerdes T, Kirkpatrick CJ. Induction of apoptosis in human microvascular endothelial cells by divalent cobalt ions. Evidence for integrin-mediated signaling via the cytoskeleton. J Mater Sci Mater Med. 2001;12: 955–958. pmid:15348347
- 42. Lukasiewicz A, Wozniak I. Interaction between the metals in cobalt(II)-copper(II), cobalt(II)-chromium(III) and iron(II)-chromium(III) cation pairs in the presence of α-amino acids and acetat anion in queous solutions. J Chem Soc chemmical Commun. 1989; 288–289.
- 43. Salazar A, Keusgen M, Von Hagen J. Amino acids in the cultivation of mammalian cells. Amino Acids. 2016;48: 1161–1171. pmid:26832172